Search Results - "Hunt, Jonathan T."

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma by Hunt, Jonathan T., Chambers, Laura M., Yao, Meng, Joehlin-Price, Amy, Debernardo, Robert, Rose, Peter G.

“…•No partial or complete responses to pembrolizumab and lenvatinib therapy were observed in advanced or recurrent UCS.•Median PFS and OS following pembrolizumab…”
Get full text

Effect of contraceptive hormonal therapy on mammographic breast density: A longitudinal cohort study by Hunt, Jonathan T., Kamat, Rachel, Yao, Meng, Sharma, Nidhi, Batur, Pelin

“…Evaluate the longitudinal relationship between mammographic density and hormonal contraceptive use in late reproductive-aged women. Patients aged 35–50 years…”
Get full text

Screening for developmental dysplasia of the hip following external cephalic version by Hoffer, Alison M., Morrow, Brianne W., McGlynn, Andrea F., Hunt, Jonathan T.

Get full text

Secondary somatic glioblastoma arising from a mature ovarian cystic teratoma in a patient with underlying Li-Fraumeni syndrome by Bussies, Parker L., Chau, Danielle B., Hunt, Jonathan T., Policarpio-Nicolas, Maria Luisa C., Friedman, Cameron, McKenney, Jesse K., Yeaney, Gabrielle A., Peereboom, David M., Beffa, Lindsey

“…•First report of a secondary somatic glioblastoma arising from MCT-MT in a patient with underlying Li-Fraumeni syndrome.•The rarity of glioblastoma arising…”
Get full text

Secondary somatic glioblastoma arising from a mature ovarian cystic teratoma in a patient with underlying Li-Fraumeni syndrome by Bussies, Parker L, Chau, Danielle B, Hunt, Jonathan T, Policarpio-Nicolas, Maria Luisa C, Friedman, Cameron, McKenney, Jesse K, Yeaney, Gabrielle A, Peereboom, David M, Beffa, Lindsey

Get full text

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma by Hunt, Jonathan T, Chambers, Laura M, Yao, Meng, Joehlin-Price, Amy, Debernardo, Robert, Rose, Peter G

“…OBJECTIVESTo investigate the efficacy of pembrolizumab plus lenvatinib as a second-line or later-line therapy in women with advanced or recurrent uterine…”
Get full text